Noveris Health Sciences is trading 22.95% down at $0.23, with the decline appearing primarily tied to broader risk-off sentiment rather than new corporate news.
- On August 18, 2026, the Nasdaq Composite was down 1.07% and the S&P 500 was down 0.44%.
- No confirmed company-specific announcement or catalyst was identified.
- Management previously said it was unaware of any material change behind unusual activity.